IRADIMED Sees FY23 Adjusted EPS Of $1.48-$1.51 Versus Consensus Of $1.26 And Prior Range Of $1.37-$1.40
Portfolio Pulse from Benzinga Newsdesk
IRADIMED has updated its FY23 adjusted EPS forecast to $1.48-$1.51, up from the previous range of $1.37-$1.40. This new projection surpasses the consensus estimate of $1.26.
November 03, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IRADIMED's updated FY23 adjusted EPS forecast is higher than the consensus estimate, indicating strong future performance.
IRADIMED's updated EPS forecast for FY23 is higher than the consensus estimate, which is a positive signal for the company's future performance. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100